These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 346193)
1. Chemotherapy of malignant hemangiopericytoma. Wong PP; Yagoda A Cancer; 1978 Apr; 41(4):1256-60. PubMed ID: 346193 [TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma in the adult: effective combination chemotherapy. Dosik GM; Rodriguez V; Benjamin RS; Bodey GP Cancer; 1978 Jan; 41(1):56-63. PubMed ID: 626943 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate. Klepp O; Klepp R; Host H; Asbjornsen G; Talle K; Stenwig AE Cancer; 1977 Aug; 40(2):638-46. PubMed ID: 70266 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin. Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798 [TBL] [Abstract][Full Text] [Related]
5. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial. Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT; Palshof T Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
7. Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination. Wittes RE; Wittes JT; Golbey RB Cancer; 1978 Feb; 41(2):415-21. PubMed ID: 343907 [TBL] [Abstract][Full Text] [Related]
8. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas. Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922 [No Abstract] [Full Text] [Related]
9. Treatment of advanced malignant hemangiopericytoma with combination adriamycin and DTIC: a report of four cases. Beadle GF; Hillcoat BL J Surg Oncol; 1983 Mar; 22(3):167-70. PubMed ID: 6682161 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease. Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975 [TBL] [Abstract][Full Text] [Related]
11. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate. Wittes RE; Hopfan S; Hilaris B; Golbey RB; Melamed M; Martini N Cancer; 1977 Aug; 40(2):653-9. PubMed ID: 196737 [No Abstract] [Full Text] [Related]
12. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974 [TBL] [Abstract][Full Text] [Related]
13. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin. Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Legha SS; Valdivieso M; Nelson RS; Benjamin RS; Bodey GP Cancer Treat Rep; 1977 Dec; 61(9):1699-703. PubMed ID: 597818 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer. Mattsson W; Arwidi A; von Eyben F; Lindholm CE Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543 [TBL] [Abstract][Full Text] [Related]
16. A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas. Creagan ET; Edmonson JH; Hahn RG; Ahmann DL; Bisel HF; Eagan RT Med Pediatr Oncol; 1978; 4(1):85-6. PubMed ID: 625266 [TBL] [Abstract][Full Text] [Related]
17. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma]. Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011 [No Abstract] [Full Text] [Related]
18. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. De Lena M; Brambilla C; Morabito A; Bonadonna G Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104 [TBL] [Abstract][Full Text] [Related]
19. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293 [TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report. Goldman RL; Jones SE; Heusinkveld RS Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]